A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being ...

Scientists are exploring using earpiece microphones, also known as hearables, to detect and 'listen' to early signs of ...

Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. Research shows that the drug activates the cannabinoid ...

These sleep aflictions are now recognised in most cases of early dementia – this new discovery could lead to earlier ...

Blarcamesine potential novel oral treatment to target upstream Alzheimer’s disease pathology through autophagy enhancementImpairment of autophagy ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

Activation of SIGMAR1 is expected to restore cellular homeostasis by inducing autophagy, which may slow neurodegeneration in patients with early AD.

Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's ...

Parkinson's and dementia patients are known to have diminished ... Meanwhile, recent analysis by the Alzheimer's Society estimates the overall annual cost of the dementia to the UK is £42billion ...

Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...

Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...